Back to search

Article

Lactoferrin Levels in Cerebrospinal Fluid Exhibit Differential Associations with Alzheimer’s Disease

2026-07-07

Abstract excerpt

<title>Abstract</title> <p>Lactoferrin has been proposed as a minimally invasive biomarker for Alzheimer’s disease (AD), but its relationship with established AD pathology remains uncertain. We analyzed paired cerebrospinal fluid (CSF) and plasma SOMAscan proteomic profiles from 1,367 participants in the ACE Alzheimer Center Barcelona cohort, focusing on two lactoferrin-targeting SOMAmers, Seq.14755.4 (LTF1) and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dc02a23f-c7fe-5149-9a66-d7c0ecc1faab
DOI
10.21203/rs.3.rs-9678397/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Lactoferrin Levels in Cerebrospinal Fluid Exhibit Differential Associations with Alzheimer’s DiseaseDOI 10.21203/rs.3.rs-9678397/v1
Multi-platform proteomic analysis of Alzheimer’s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisomeSemantic proximity
A leakage-controlled multi-compartment benchmark of fluid biomarkers for predicting mild cognitive impairment to Alzheimer’s disease conversion: plasma, CSF, and high-plex omics in a single cohortSemantic proximity
Lactoferrin in cerebrospinal fluid and saliva is not a diagnostic biomarker for Alzheimer's disease in a mixed memory clinic populationSemantic proximity
Saliva Proteome, Metabolome and Microbiome Signatures for Detection of Alzheimer’s DiseaseSemantic proximity
Comparison of plasma soluble and extracellular vesicles-associated biomarkers in Alzheimer’s Disease patients and cognitively normal individualsSemantic proximity
Addressing inter-individual variability in CSF levels of brain-derived proteins across neurodegenerative diseasesSemantic proximity
Addressing inter individual variability in CSF levels of brain derived proteins across neurodegenerative diseasesSemantic proximity
Head-to-head comparison of aptamer- and antibody-based proteomic platforms in human cerebrospinal fluid samples from a real-world memory clinic cohortSemantic proximity
CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive declineSemantic proximity
CSF neurogranin levels as a biomarker in Alzheimer’s disease and frontotemporal lobar degeneration: a cross-sectional analysisSemantic proximity
Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia withC9orf72hexanucleotide repeat expansionSemantic proximity
Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study.Semantic proximity
Select a neighboring publication to make it the new centre.